LUCENT DIAGNOSTICS Trademark

Trademark Overview

On Wednesday, December 6, 2023, a trademark application was filed for LUCENT DIAGNOSTICS with the United States Patent and Trademark Office. The USPTO has given the LUCENT DIAGNOSTICS trademark a serial number of 98302027. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Wednesday, September 25, 2024. This trademark is owned by Quanterix Corporation. The LUCENT DIAGNOSTICS trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic reagents and assays for testing bodily fluids; diagnostic testing kits comprised of primarily medical diagnostic reagents and assays and also including specimen containers for testing of bodily fluids for use in disease detection, diagnosing, monitoring, reporting, and treating, namely, neurodegenerative diseases and neurological diseases; clinical diagnostic tests composed of medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic reagents in the nature of medical diagnostic reagents and assay kits composed of medical diagnostic assays for testing body fluids; clinical diagnostic instrumentation and consumables, namely, medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic instrumentation in the nature of clinical medical reagents

diagnostic laboratory services, namely, medical diagnostic services in the nature of analysis, detection and identification of components in bodily samples; medical diagnostic services for determining diseases or disorders, monitoring diseases or disorders, and determining the therapeutic efficacy of treatments for diseases or disorders; clinical diagnostic testing services being medical testing services; clinical diagnostic laboratory and reporting services, namely, medical diagnostic testing, monitoring, and reporting services; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services; medical testing for disease, illness, and pathology tracking, and treatment purposes
lucent diagnostics

General Information

Serial Number98302027
Word MarkLUCENT DIAGNOSTICS
Filing DateWednesday, December 6, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic reagents and assays for testing bodily fluids; diagnostic testing kits comprised of primarily medical diagnostic reagents and assays and also including specimen containers for testing of bodily fluids for use in disease detection, diagnosing, monitoring, reporting, and treating, namely, neurodegenerative diseases and neurological diseases; clinical diagnostic tests composed of medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic reagents in the nature of medical diagnostic reagents and assay kits composed of medical diagnostic assays for testing body fluids; clinical diagnostic instrumentation and consumables, namely, medical diagnostic reagents and assays for testing of body fluids; clinical diagnostic instrumentation in the nature of clinical medical reagents
Goods and Servicesdiagnostic laboratory services, namely, medical diagnostic services in the nature of analysis, detection and identification of components in bodily samples; medical diagnostic services for determining diseases or disorders, monitoring diseases or disorders, and determining the therapeutic efficacy of treatments for diseases or disorders; clinical diagnostic testing services being medical testing services; clinical diagnostic laboratory and reporting services, namely, medical diagnostic testing, monitoring, and reporting services; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic testing, monitoring and reporting services; medical testing for disease, illness, and pathology tracking, and treatment purposes
NOT AVAILABLEDIAGNOSTICS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 3, 2024
Primary Code005
First Use Anywhere DateThursday, July 6, 2023
First Use In Commerce DateThursday, July 6, 2023
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, August 12, 2024
Primary Code044
First Use Anywhere DateThursday, July 6, 2023
First Use In Commerce DateThursday, July 6, 2023

Trademark Owner History

Party NameQuanterix Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBillerica, MA 01821

Trademark Events

Event DateEvent Description
Wednesday, December 6, 2023NEW APPLICATION ENTERED
Monday, March 4, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 6, 2024ASSIGNED TO EXAMINER
Monday, July 8, 2024NON-FINAL ACTION E-MAILED
Monday, August 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 8, 2024NON-FINAL ACTION WRITTEN
Monday, July 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, September 25, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 25, 2024SUSPENSION LETTER WRITTEN

Related Keywords

diagnostics lucent diagnostic medical testing services clinical reagents diseases fluids assays namely